956239-35-3Relevant academic research and scientific papers
2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
-
Page/Page column 7-8, (2008/06/13)
Disclosed is an isolated compound of the formula: along with methods of detecting it and of minimizing it in improved pharmaceutical compositions of rosiglitazone maleate.
PREPARATION OF ROSIGLITAZONE AND ITS SALTS
-
Page/Page column 9, (2008/06/13)
The present invention relates to rosiglitazone and its pharmaceutically acceptable salts free of at least one of the process related impurities, in particular the dehydro and the succinic acid impurities of rosiglitazone, wherein said impurities are present in an amount of about 05 mg to not more than about 15 mg, and processes for their preparation.
2-N-{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2-4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
-
Page/Page column 11-13, (2008/06/13)
Disclosed is an isolated compound of the formula: along with methods of detecting it and of minimizing it in improved pharmaceutical compositions of rosiglitazone maleate.
2-N-(5-[[4-(2-(METHYL-2-PYRIDINYLAMINO) ETHOXY] PHENYL]METHYL]-2,4-THIAZOLIDINEDIONE) BUTANEDIOIC ACID, METHODS OF PREPARATION AND COMPOSITIONS WITH ROSIGLITAZONE MALEATE
-
Page/Page column 25-27, (2008/06/13)
Disclosed is an isolated compound of the formula (I) along with methods of detecting it and of minimizing it in improved pharmaceutical compositions of rosiglitazone maleate.
